Are we losing artemisinin combination therapy already?

Lancet

Volumn 366, Issue 9501, 2005, Pages 1908-1909

  Duffy, Patrick E ^a   Sibley, Carol Hopkins ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; FANSIDAR; HALOFANTRINE; MEFLOQUINE; QUININE;

AFRICA; DISEASE TRANSMISSION; DNA POLYMORPHISM; DRUG EFFICACY; GENE MUTATION; HUMAN; MALARIA; MORTALITY; NOTE; PRIORITY JOURNAL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

EID: 28244449796     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)67768-9     Document Type: Note

References (13)

1. JF Trape The public health impact of chloroquine resistance in Africa Am J Trop Med Hyg 64 suppl 1-2 2001 12 17
2. A Attaran, KI Barnes, C Curtis WHO, the Global Fund, and medical malpractice in malaria treatment Lancet 363 2004 237 240
3. F Nosten, TT Hien, NJ White Use of artemisinin derivatives for the control of malaria Med Trop (Mars) 58 suppl 3 1998 45 49
4. C Wongsrichanalai, J Sirichaisinthop, JJ Karwacki Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders Southeast Asian J Trop Med Public Health 32 2001 41 49
5. F Nosten, M van Vugt, R Price Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study Lancet 356 2000 297 302
6. Roll Back Malaria World malaria report 2005 http://rbm.who.int/wmr2005/ html/1-3.htm1_3_1 (accessed Aug 26, 2005)
7. R Jambou, E Legrand, M Niang Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 Lancet 366 1960-63
8. U Eckstein-Ludwig, RJ Webb, ID Van Goethem Artemisinins target the SERCA of Plasmodium falciparum Nature 424 2003 957 961
9. TJ Anderson, S Nair, H Qin Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance? Antimicrob Agents Chemother 49 2005 2180 2188
10. A Yeka, K Banek, N Bakyaita Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda PLoS Med 2 2005 e190
11. International Artemisinin Study Group Artesunate combinations for treatment of malaria: meta-analysis Lancet 363 2004 9 17
12. N Durrani, T Leslie, S Rahim, K Graham, F Ahmad, M Rowland Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan Trop Med Int Health 10 2005 521 529
13. C Sisowath, J Stromberg, A Martensson In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem) J Infect Dis 191 2005 1014 1017